血小板凝集装置市场规模、份额及成长分析（按产品、应用、最终用户和地区划分）－产业预测（2026-2033）

全球血小板凝集装置市场规模预计在 2024 年达到 5.9051 亿美元，从 2025 年的 6.3066 亿美元增长到 2033 年的 10.675 亿美元，在预测期（2026-2033 年）内复合年增长率为 6.8%。

全球血小板凝集分析仪市场正经历显着成长，这主要得益于多种驱动因素​​。目标疾病盛行率的上升和老年人口的不断增长是推动这一增长趋势的重要因素。血小板凝集测量技术的创新，对于分析血小板功能及相关疾病至关重要，也是推动市场动态。此外，产业领导者与学术机构之间合作的加强，以及临床研究的蓬勃发展，都在推动市场创新。然而，市场仍面临许多挑战，例如临床操作流程的限制、美国医疗保健体系的改革以及训练有素的专业人员短缺等，这些都可能阻碍市场的潜在发展。总而言之，该市场呈现出充满活力的格局，既蕴藏着机会，也面临挑战。

全球血小板凝集装置市场驱动因素

全球对血小板凝集分析仪的需求不断增长，为该市场的相关人员带来了巨大的发展机会。推动这项需求激增的主要因素是全球慢性病和出血性疾病盛行率的上升。随着这些疾病的日益普遍，对先进诊断和监测工具的需求也随之增加。血小板凝集分析仪在此背景下至关重要，因为它们能够评估血小板功能，并且对于诊断和治疗各种凝血相关疾病必不可少。预计其在医疗保健领域的重要性将在不久的将来推动市场扩张。

限制全球血小板凝集装置市场的因素

全球血小板凝集仪市场面临着阻碍其扩张的许多挑战。其中一个主要障碍是这些设备的高成本，这给医疗机构和设施带来了沉重的经济负担，往往限制了它们投资此类先进诊断技术的能力。此外，缺乏训练有素的操作和维护人员也加剧了这个问题，导致设备利用率低下，效率低。高成本和缺乏专业技术人员的双重限制阻碍了市场的成长潜力，并最终限制了患者和医疗服务提供者获得必要的诊断能力。

全球血小板凝集装置市场趋势

由于全球范围内止血功能障碍的发生率不断上升，血小板凝集设备市场正经历强劲成长。影响血液凝固过程的疾病发生率不断攀升，导致对有效诊断工具的需求日益增长，尤其是那些能够评估血小板功能和识别凝血障碍的工具。随着医疗专业人员认识到血小板凝集检测在疾病管理中的重要性，对创新可靠设备的需求也随之飙升。技术进步以及临床医生对准确止血评估益处的认识不断提高，也推动了这一趋势，预计这将在未来几年持续促进市场扩张。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管环境

全球血小板凝集装置市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 系统
• 试剂
• 耗材和配件

全球血小板凝集装置市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 临床应用
• 研究用途

全球血小板凝集装置市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 医院和诊所
• 诊断实验室
• 研究和学术机构
• 其他的

全球血小板凝集装置市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• F. Hoffmann-La Roche Ltd.（Switzerland）
• Siemens Healthineers AG（Germany）
• Haemonetics Corporation（USA）
• Sysmex Corporation（Japan）
• Helena Laboratories Corporation（USA）
• Chrono-Log Corporation（USA）
• Drucker Diagnostics（USA）
• Werfen（Spain）
• Aggredyne, Inc.（USA）
• Sentinel CH. SpA（Italy）
• Tem Group（Germany）
• LSI Medience Corporation（Japan）
• Matis Medical Inc.（USA）
• Hart Biologicals（UK）

结论与建议

Global Platelet Aggregation Devices Market size was valued at USD 590.51 Million in 2024 and is poised to grow from USD 630.66 Million in 2025 to USD 1067.5 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global market for platelet aggregation devices is witnessing substantial growth due to various driving factors. A rising prevalence of targeted diseases, alongside an expanding elderly population, significantly contributes to this upward trend. Innovations in platelet aggregometry, crucial for analyzing platelet function and related disorders, are also enhancing market dynamics. Moreover, increased partnerships between industry leaders and academic institutions, coupled with a surge in clinical studies, is spurring innovation within the market. However, challenges remain, including procedural limitations in healthcare, unfavorable reforms within the U.S. healthcare system, and a lack of adequately trained professionals, which could hinder potential market advancement. Overall, the market presents a dynamic landscape filled with both opportunities and challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Platelet Aggregation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Platelet Aggregation Devices Market Segments Analysis

Global Platelet Aggregation Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Systems, Reagents and Consumables and Accessories. Based on Application, the market is segmented into Clinical Applications and Research Applications. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Platelet Aggregation Devices Market

The growing global demand for platelet aggregation devices presents significant growth prospects for stakeholders in this market. This surge in demand is largely driven by the increasing prevalence of chronic and bleeding disorders around the world. As these medical conditions become more widespread, there is a corresponding need for sophisticated diagnostic and monitoring tools. Platelet aggregation devices are crucial in this context, as they facilitate the assessment of platelet function and are essential for the diagnosis and management of various coagulation-related disorders. Their importance in healthcare is expected to propel market expansion in the foreseeable future.

Restraints in the Global Platelet Aggregation Devices Market

The global platelet aggregation devices market encounters significant challenges that hinder its expansion. One primary obstacle is the elevated cost of these devices, which presents a financial burden for healthcare organizations and facilities, often restricting their capability to invest in such advanced diagnostic technologies. In addition, the lack of adequately trained personnel to operate and maintain these devices exacerbates the situation, resulting in underutilization and inefficiencies. This combination of high expenses and a shortfall of skilled expertise hampers the market's growth potential, ultimately limiting access to essential diagnostic capabilities for patients and healthcare providers alike.

Market Trends of the Global Platelet Aggregation Devices Market

The Global Platelet Aggregation Devices market is experiencing robust growth fueled by the increasing prevalence of hemostasis disorders worldwide. The rising incidence of conditions affecting blood clotting processes has heightened the need for effective diagnostic tools, particularly those that assess platelet function and identify coagulation abnormalities. As healthcare professionals recognize the critical importance of platelet aggregation testing in managing these disorders, the demand for innovative and reliable devices is surging. This trend is also supported by advancements in technology and growing awareness among clinicians regarding the benefits of accurate hemostasis evaluation, positioning the market for sustained expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Platelet Aggregation Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Systems
• Reagents
• Consumables and Accessories

Global Platelet Aggregation Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Applications
• Research Applications

Global Platelet Aggregation Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Research and Academic Institutes
• Others

Global Platelet Aggregation Devices Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chrono-Log Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drucker Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aggredyne, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sentinel CH. SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tem Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LSI Medience Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matis Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hart Biologicals (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations